Fluorine in PDB 5mo4: ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib
Enzymatic activity of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib
All present enzymatic activity of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib:
2.7.10.2;
Protein crystallography data
The structure of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib, PDB code: 5mo4
was solved by
S.W.Cowan-Jacob,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
59.14 /
2.17
|
Space group
|
C 2 2 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
118.280,
124.130,
74.660,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.2 /
21.7
|
Other elements in 5mo4:
The structure of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib
(pdb code 5mo4). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 5 binding sites of Fluorine where determined in the
ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib, PDB code: 5mo4:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
Fluorine binding site 1 out
of 5 in 5mo4
Go back to
Fluorine Binding Sites List in 5mo4
Fluorine binding site 1 out
of 5 in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F601
b:31.4
occ:1.00
|
F4
|
A:NIL601
|
0.0
|
31.4
|
1.0
|
C2
|
A:NIL601
|
1.4
|
31.3
|
1.0
|
F3
|
A:NIL601
|
2.2
|
31.1
|
1.0
|
F1
|
A:NIL601
|
2.2
|
30.8
|
1.0
|
C5
|
A:NIL601
|
2.4
|
31.4
|
1.0
|
C6
|
A:NIL601
|
2.8
|
32.0
|
1.0
|
CD1
|
A:ILE312
|
3.6
|
33.7
|
1.0
|
C12
|
A:NIL601
|
3.7
|
29.7
|
1.0
|
CD2
|
A:LEU317
|
3.8
|
17.8
|
1.0
|
CE2
|
A:PHE378
|
3.9
|
44.4
|
1.0
|
O
|
A:HOH721
|
4.1
|
38.7
|
1.0
|
CD1
|
A:LEU373
|
4.2
|
28.2
|
1.0
|
CD2
|
A:HIS380
|
4.2
|
32.7
|
1.0
|
C8
|
A:NIL601
|
4.3
|
35.1
|
1.0
|
CD2
|
A:LEU373
|
4.3
|
28.6
|
1.0
|
CZ
|
A:PHE378
|
4.5
|
43.2
|
1.0
|
CG2
|
A:ILE312
|
4.5
|
33.0
|
1.0
|
CD2
|
A:PHE378
|
4.6
|
41.2
|
1.0
|
CG1
|
A:ILE312
|
4.6
|
31.5
|
1.0
|
NE2
|
A:HIS380
|
4.7
|
32.6
|
1.0
|
C11
|
A:NIL601
|
4.9
|
28.6
|
1.0
|
CG
|
A:LEU373
|
4.9
|
29.0
|
1.0
|
|
Fluorine binding site 2 out
of 5 in 5mo4
Go back to
Fluorine Binding Sites List in 5mo4
Fluorine binding site 2 out
of 5 in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F601
b:31.1
occ:1.00
|
F3
|
A:NIL601
|
0.0
|
31.1
|
1.0
|
C2
|
A:NIL601
|
1.4
|
31.3
|
1.0
|
F4
|
A:NIL601
|
2.2
|
31.4
|
1.0
|
F1
|
A:NIL601
|
2.2
|
30.8
|
1.0
|
C5
|
A:NIL601
|
2.4
|
31.4
|
1.0
|
C12
|
A:NIL601
|
3.1
|
29.7
|
1.0
|
C
|
A:ALA399
|
3.2
|
28.4
|
1.0
|
O
|
A:ALA399
|
3.3
|
27.0
|
1.0
|
C6
|
A:NIL601
|
3.4
|
32.0
|
1.0
|
NE2
|
A:HIS380
|
3.4
|
32.6
|
1.0
|
CA
|
A:ALA399
|
3.5
|
23.7
|
1.0
|
CD2
|
A:HIS380
|
3.5
|
32.7
|
1.0
|
N
|
A:ASP400
|
3.6
|
26.6
|
1.0
|
CB
|
A:ASP400
|
3.8
|
28.7
|
1.0
|
N
|
A:ALA399
|
3.8
|
23.3
|
1.0
|
CD2
|
A:LEU317
|
4.1
|
17.8
|
1.0
|
O
|
A:VAL398
|
4.1
|
22.5
|
1.0
|
C
|
A:VAL398
|
4.1
|
25.2
|
1.0
|
O
|
A:HOH721
|
4.2
|
38.7
|
1.0
|
CG1
|
A:VAL398
|
4.2
|
25.7
|
1.0
|
CA
|
A:ASP400
|
4.3
|
27.3
|
1.0
|
C11
|
A:NIL601
|
4.4
|
28.6
|
1.0
|
C8
|
A:NIL601
|
4.6
|
35.1
|
1.0
|
CE1
|
A:HIS380
|
4.6
|
31.7
|
1.0
|
CG
|
A:HIS380
|
4.8
|
30.5
|
1.0
|
CB
|
A:ALA399
|
4.9
|
24.5
|
1.0
|
O17
|
A:NIL601
|
5.0
|
28.7
|
1.0
|
C9
|
A:NIL601
|
5.0
|
30.7
|
1.0
|
CB
|
A:VAL398
|
5.0
|
25.7
|
1.0
|
|
Fluorine binding site 3 out
of 5 in 5mo4
Go back to
Fluorine Binding Sites List in 5mo4
Fluorine binding site 3 out
of 5 in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F601
b:30.8
occ:1.00
|
F1
|
A:NIL601
|
0.0
|
30.8
|
1.0
|
C2
|
A:NIL601
|
1.4
|
31.3
|
1.0
|
F3
|
A:NIL601
|
2.2
|
31.1
|
1.0
|
F4
|
A:NIL601
|
2.2
|
31.4
|
1.0
|
C5
|
A:NIL601
|
2.4
|
31.4
|
1.0
|
C12
|
A:NIL601
|
2.8
|
29.7
|
1.0
|
CD2
|
A:LEU317
|
3.5
|
17.8
|
1.0
|
C6
|
A:NIL601
|
3.6
|
32.0
|
1.0
|
O
|
A:VAL398
|
3.8
|
22.5
|
1.0
|
CG2
|
A:VAL318
|
3.9
|
24.2
|
1.0
|
CA
|
A:ALA399
|
4.2
|
23.7
|
1.0
|
C11
|
A:NIL601
|
4.2
|
28.6
|
1.0
|
CD1
|
A:ILE312
|
4.2
|
33.7
|
1.0
|
CG2
|
A:ILE312
|
4.2
|
33.0
|
1.0
|
CB
|
A:LEU317
|
4.2
|
19.0
|
1.0
|
C
|
A:VAL398
|
4.4
|
25.2
|
1.0
|
N
|
A:VAL318
|
4.4
|
21.1
|
1.0
|
CG
|
A:LEU317
|
4.5
|
20.1
|
1.0
|
C
|
A:ALA399
|
4.6
|
28.4
|
1.0
|
N
|
A:ALA399
|
4.6
|
23.3
|
1.0
|
O
|
A:VAL318
|
4.7
|
25.9
|
1.0
|
C8
|
A:NIL601
|
4.8
|
35.1
|
1.0
|
CA
|
A:LEU317
|
4.8
|
20.0
|
1.0
|
N
|
A:ASP400
|
4.9
|
26.6
|
1.0
|
C
|
A:LEU317
|
4.9
|
24.0
|
1.0
|
O17
|
A:NIL601
|
4.9
|
28.7
|
1.0
|
CB
|
A:ILE312
|
5.0
|
32.1
|
1.0
|
C9
|
A:NIL601
|
5.0
|
30.7
|
1.0
|
|
Fluorine binding site 4 out
of 5 in 5mo4
Go back to
Fluorine Binding Sites List in 5mo4
Fluorine binding site 4 out
of 5 in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F602
b:28.6
occ:1.00
|
F29
|
A:AY7602
|
0.0
|
28.6
|
1.0
|
C28
|
A:AY7602
|
1.4
|
29.4
|
1.0
|
F30
|
A:AY7602
|
2.2
|
31.4
|
1.0
|
O22
|
A:AY7602
|
2.2
|
28.8
|
1.0
|
CL
|
A:AY7602
|
2.7
|
26.2
|
1.0
|
C19
|
A:AY7602
|
3.6
|
28.7
|
1.0
|
CB
|
A:ALA363
|
3.6
|
23.0
|
1.0
|
CE1
|
A:PHE512
|
3.6
|
37.6
|
1.0
|
CD1
|
A:LEU360
|
3.7
|
27.0
|
1.0
|
CG1
|
A:VAL487
|
4.0
|
25.4
|
1.0
|
CZ
|
A:PHE512
|
4.0
|
36.1
|
1.0
|
CA
|
A:LEU360
|
4.2
|
21.9
|
1.0
|
CG2
|
A:VAL487
|
4.2
|
27.2
|
1.0
|
CD1
|
A:LEU448
|
4.2
|
31.8
|
1.0
|
C18
|
A:AY7602
|
4.4
|
29.5
|
1.0
|
C20
|
A:AY7602
|
4.5
|
25.5
|
1.0
|
CD1
|
A:PHE512
|
4.6
|
38.1
|
1.0
|
CB
|
A:LEU360
|
4.6
|
22.4
|
1.0
|
CG
|
A:LEU448
|
4.7
|
31.3
|
1.0
|
CB
|
A:VAL487
|
4.8
|
27.4
|
1.0
|
O
|
A:LEU359
|
4.8
|
19.3
|
1.0
|
N
|
A:LEU360
|
4.8
|
21.3
|
1.0
|
CG
|
A:LEU360
|
4.8
|
27.4
|
1.0
|
CD1
|
A:ILE521
|
4.9
|
37.5
|
1.0
|
|
Fluorine binding site 5 out
of 5 in 5mo4
Go back to
Fluorine Binding Sites List in 5mo4
Fluorine binding site 5 out
of 5 in the ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of ABL1 Kinase (T334I_D382N) in Complex with Asciminib and Nilotinib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F602
b:31.4
occ:1.00
|
F30
|
A:AY7602
|
0.0
|
31.4
|
1.0
|
C28
|
A:AY7602
|
1.3
|
29.4
|
1.0
|
F29
|
A:AY7602
|
2.2
|
28.6
|
1.0
|
O22
|
A:AY7602
|
2.3
|
28.8
|
1.0
|
CL
|
A:AY7602
|
2.5
|
26.2
|
1.0
|
C19
|
A:AY7602
|
3.0
|
28.7
|
1.0
|
C18
|
A:AY7602
|
3.1
|
29.5
|
1.0
|
O
|
A:LEU359
|
3.2
|
19.3
|
1.0
|
C
|
A:LEU359
|
3.3
|
23.1
|
1.0
|
N
|
A:LEU360
|
3.4
|
21.3
|
1.0
|
CA
|
A:LEU360
|
3.4
|
21.9
|
1.0
|
CG2
|
A:ILE451
|
3.6
|
24.6
|
1.0
|
CB
|
A:LEU359
|
3.8
|
21.1
|
1.0
|
CB
|
A:ALA363
|
3.8
|
23.0
|
1.0
|
C20
|
A:AY7602
|
4.1
|
25.5
|
1.0
|
CA
|
A:LEU359
|
4.1
|
21.5
|
1.0
|
CB
|
A:LEU360
|
4.3
|
22.4
|
1.0
|
C17
|
A:AY7602
|
4.3
|
29.0
|
1.0
|
C
|
A:LEU360
|
4.6
|
24.6
|
1.0
|
CB
|
A:ILE451
|
4.6
|
24.8
|
1.0
|
CD1
|
A:LEU360
|
4.7
|
27.0
|
1.0
|
CD1
|
A:ILE521
|
4.9
|
37.5
|
1.0
|
O
|
A:ALA356
|
4.9
|
22.0
|
1.0
|
O
|
A:LEU360
|
4.9
|
24.4
|
1.0
|
|
Reference:
A.A.Wylie,
J.Schoepfer,
W.Jahnke,
S.W.Cowan-Jacob,
A.Loo,
P.Furet,
A.L.Marzinzik,
X.Pelle,
J.Donovan,
W.Zhu,
S.Buonamici,
A.Q.Hassan,
F.Lombardo,
V.Iyer,
M.Palmer,
G.Berellini,
S.Dodd,
S.Thohan,
H.Bitter,
S.Branford,
D.M.Ross,
T.P.Hughes,
L.Petruzzelli,
K.G.Vanasse,
M.Warmuth,
F.Hofmann,
N.J.Keen,
W.R.Sellers.
The Allosteric Inhibitor ABL001 Enables Dual Targeting of Bcr-ABL1. Nature V. 543 733 2017.
ISSN: ESSN 1476-4687
PubMed: 28329763
DOI: 10.1038/NATURE21702
Page generated: Thu Aug 1 11:44:42 2024
|